JP2021531246A5 - - Google Patents

Info

Publication number
JP2021531246A5
JP2021531246A5 JP2020573032A JP2020573032A JP2021531246A5 JP 2021531246 A5 JP2021531246 A5 JP 2021531246A5 JP 2020573032 A JP2020573032 A JP 2020573032A JP 2020573032 A JP2020573032 A JP 2020573032A JP 2021531246 A5 JP2021531246 A5 JP 2021531246A5
Authority
JP
Japan
Prior art keywords
seq
peptide according
isolated peptide
amino acid
proline
Prior art date
Application number
JP2020573032A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020012478A5 (https=
JP7395517B2 (ja
JP2021531246A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2019/050774 external-priority patent/WO2020012478A2/en
Publication of JP2021531246A publication Critical patent/JP2021531246A/ja
Publication of JPWO2020012478A5 publication Critical patent/JPWO2020012478A5/ja
Publication of JP2021531246A5 publication Critical patent/JP2021531246A5/ja
Priority to JP2023201767A priority Critical patent/JP7682248B2/ja
Application granted granted Critical
Publication of JP7395517B2 publication Critical patent/JP7395517B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020573032A 2018-07-11 2019-07-10 ペプチド化合物およびその治療的用途 Active JP7395517B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023201767A JP7682248B2 (ja) 2018-07-11 2023-11-29 ペプチド化合物およびその治療的用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL260555 2018-07-11
IL26055518 2018-07-11
PCT/IL2019/050774 WO2020012478A2 (en) 2018-07-11 2019-07-10 Peptide compounds and therapeutic uses of same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023201767A Division JP7682248B2 (ja) 2018-07-11 2023-11-29 ペプチド化合物およびその治療的用途

Publications (4)

Publication Number Publication Date
JP2021531246A JP2021531246A (ja) 2021-11-18
JPWO2020012478A5 JPWO2020012478A5 (https=) 2022-07-19
JP2021531246A5 true JP2021531246A5 (https=) 2022-07-19
JP7395517B2 JP7395517B2 (ja) 2023-12-11

Family

ID=69141375

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020573032A Active JP7395517B2 (ja) 2018-07-11 2019-07-10 ペプチド化合物およびその治療的用途
JP2023201767A Active JP7682248B2 (ja) 2018-07-11 2023-11-29 ペプチド化合物およびその治療的用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023201767A Active JP7682248B2 (ja) 2018-07-11 2023-11-29 ペプチド化合物およびその治療的用途

Country Status (20)

Country Link
US (2) US11912790B2 (https=)
EP (2) EP3820882B1 (https=)
JP (2) JP7395517B2 (https=)
KR (1) KR102880543B1 (https=)
CN (1) CN112351989B (https=)
AU (2) AU2019300567B2 (https=)
BR (1) BR112020024748A2 (https=)
CA (1) CA3100961A1 (https=)
CO (1) CO2021001290A2 (https=)
EA (1) EA202190249A1 (https=)
ES (1) ES3026158T3 (https=)
HR (1) HRP20250746T1 (https=)
HU (1) HUE072141T2 (https=)
IL (2) IL317252A (https=)
MX (1) MX2021000264A (https=)
PL (1) PL3820882T3 (https=)
RS (1) RS66946B1 (https=)
SG (1) SG11202012773QA (https=)
WO (1) WO2020012478A2 (https=)
ZA (1) ZA202100587B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202012773QA (en) 2018-07-11 2021-01-28 Immunity Pharma Ltd Peptide compounds and therapeutic uses of same
IL272074B2 (en) * 2020-01-15 2024-12-01 Immunity Pharma Ltd Peptide compounds and methods of treating diseases using same

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
JPS4843906B1 (https=) * 1970-08-11 1973-12-21
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
WO1997044447A2 (en) * 1996-05-03 1997-11-27 President And Fellows Of Harvard College Transcriptional activation system, activators, and uses therefor
US6861256B2 (en) * 1997-05-15 2005-03-01 The General Hospital Corporation Therapeutic and diagnostic tools for impaired glucose tolerance conditions
GB9711148D0 (en) * 1997-05-31 1997-07-23 Peptide Therapeutics Ltd Human MAFA
EP0928968A1 (en) 1998-01-12 1999-07-14 Universität Basel Screening method for apoptosis and necrosis
EP1381839A4 (en) 2001-04-03 2005-10-12 Univ Leland Stanford Junior METHOD FOR THE IMAGE OF CELL DEOD IN VIVO
US20040204340A1 (en) * 2003-04-11 2004-10-14 Guilford Pharmaceuticals, Inc. Polyprolyl inhibitors of cyclophilin
HUE024953T2 (en) * 2004-08-23 2016-02-29 Yeda Res & Dev Peptide inhibitors to mediate stress responses
JP2008528630A (ja) * 2005-02-01 2008-07-31 アテニュオン,エルエルシー 抗血管新生phscnペプチドを含む組成物
US7704953B2 (en) * 2006-02-17 2010-04-27 Mdrna, Inc. Phage displayed cell binding peptides
JP2013505230A (ja) * 2009-09-17 2013-02-14 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド 酸化ストレス関連障害を処置するためのペプチド
WO2011126882A2 (en) * 2010-03-30 2011-10-13 American Type Culture Collection Therapeutic peptides and their derivatives and therapeutic uses thereof
US20130331297A1 (en) * 2010-07-16 2013-12-12 Avantgen, Inc. Novel peptides and uses thereof
BR112013015797B1 (pt) * 2010-12-23 2021-08-31 Shell Internationale Research Maatschappij B.V. Organismo microbiano e método de produzir um derivado de acil-coa graxo
EP2715350B1 (en) * 2011-05-23 2017-09-27 Yeda Research and Development Co. Ltd. Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
US20140271666A1 (en) * 2013-03-14 2014-09-18 Immune Pharmaceuticals Ltd. Use of anti-eotaxin antibodies for treating inflammatory bowel disease
CN104045703B (zh) * 2013-03-15 2021-04-06 深圳君圣泰生物技术有限公司 一种多肽、多肽衍生物、多肽的可药用盐及药物组合物
US8802633B1 (en) * 2013-03-18 2014-08-12 Board Of Regents, The University Of Texas System Autophagy-inducing peptide analogs
ES2799404T3 (es) * 2014-07-15 2020-12-17 Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd Polipéptidos de CD44 aislados y usos de los mismos
US9453061B2 (en) * 2014-08-06 2016-09-27 Brown University Method and compositions for treatment of calcineurin-related diseases
CA2988388C (en) 2015-04-23 2022-11-22 Nantomics, Llc Cancer neoepitopes
WO2017011338A1 (en) 2015-07-10 2017-01-19 President And Fellows Of Harvard College Sortase-mediated coupling of immunogenic polysaccharide-protein conjugates and their use
SG11202012773QA (en) 2018-07-11 2021-01-28 Immunity Pharma Ltd Peptide compounds and therapeutic uses of same
IL272074B2 (en) 2020-01-15 2024-12-01 Immunity Pharma Ltd Peptide compounds and methods of treating diseases using same

Similar Documents

Publication Publication Date Title
JP5688290B2 (ja) 抗菌性ペプチド
DE60329201D1 (de) Substituierte wt1-peptide
IL262805B2 (en) Agonist agents of cd47 inducing programmed cell death and their use in the treatments of diseases associated with defects in programmed cell death
CA2489227A1 (en) Hla-a24-restricted cancer antigen peptides
CN106232616A (zh) 两亲性合成抗菌肽、其药物组合物及其用途
JP2006506942A5 (https=)
JP2020507623A5 (https=)
JP2007535910A5 (https=)
CA1337407C (en) Dimeric peptides having a stimulatory effect on haemopoiesis and a process for their preparation
JP2021531246A5 (https=)
JPWO2021070696A5 (https=)
JPWO2020012478A5 (https=)
EP2990415B1 (en) Cyclic beta defensins analogs for the treatment of infections
JP2002539829A5 (https=)
CN114080394A (zh) 新型θ-防御素类似物
HRP20250746T1 (hr) Peptidni spojevi i njihova terapijska upotreba
JP2008508363A5 (https=)
RU2021103167A (ru) Пептидные соединения и их терапевтическое применение
JP2005500390A5 (https=)
RU2024102163A (ru) Пептидные соединения и их терапевтическое применение
US20200071357A1 (en) Antimicrobial peptides
JP2008518622A5 (https=)
JPWO2008050830A1 (ja) 抗hiv剤
JPWO2019218015A5 (https=)
JP2020505324A5 (https=)